(Total Views: 678)
Posted On: 08/10/2022 5:27:52 PM
Post# of 145887
In this particular case I can understand the FDAs concerns with safety. Their product uses live bacteria from a wide variety of donors. If careful screening isn't being done harmful bacteria may get through the process. That the drug is being trialed in a type of GVHD then bacteria inducing a high immune response could kill the patients very quickly.
(8)
(0)